应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
OMER 奥麦罗制药
休市中 08-01 16:00:00 EDT
3.61
-0.26
-6.72%
盘后
3.56
-0.05
-1.39%
16:53 EDT
最高
3.83
最低
3.52
成交量
186.30万
今开
3.83
昨收
3.87
日振幅
8.01%
总市值
2.42亿
流通市值
2.33亿
总股本
6,713万
成交额
677.14万
换手率
2.89%
流通股本
6,455万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
奥麦罗制药盘中异动 股价大涨5.06%报4.05美元
市场透视 · 07-31 16:28
奥麦罗制药盘中异动 股价大涨5.06%报4.05美元
奥麦罗制药盘中异动 股价大跌5.06%
市场透视 · 07-29
奥麦罗制药盘中异动 股价大跌5.06%
奥麦罗制药盘中异动 股价大涨7.96%报4.14美元
市场透视 · 07-28
奥麦罗制药盘中异动 股价大涨7.96%报4.14美元
奥麦罗制药盘中异动 临近午盘股价大跌5.26%报3.42美元
市场透视 · 07-16
奥麦罗制药盘中异动 临近午盘股价大跌5.26%报3.42美元
奥麦罗制药盘中异动 急速拉升5.07%报3.84美元
市场透视 · 07-14
奥麦罗制药盘中异动 急速拉升5.07%报3.84美元
奥麦罗制药盘中异动 大幅拉升5.06%报3.64美元
市场透视 · 07-11
奥麦罗制药盘中异动 大幅拉升5.06%报3.64美元
奥麦罗制药盘中异动 急速拉升5.01%
市场透视 · 07-09
奥麦罗制药盘中异动 急速拉升5.01%
奥麦罗制药盘中异动 下午盘股价大跌5.00%报3.04美元
市场透视 · 07-07
奥麦罗制药盘中异动 下午盘股价大跌5.00%报3.04美元
奥麦罗制药盘中异动 股价大涨5.05%
市场透视 · 07-02
奥麦罗制药盘中异动 股价大涨5.05%
奥麦罗制药盘中异动 急速跳水5.00%报3.04美元
市场透视 · 06-30
奥麦罗制药盘中异动 急速跳水5.00%报3.04美元
奥麦罗制药盘中异动 早盘快速跳水5.00%
市场透视 · 06-26
奥麦罗制药盘中异动 早盘快速跳水5.00%
奥麦罗制药盘中异动 快速上涨5.02%
市场透视 · 06-24
奥麦罗制药盘中异动 快速上涨5.02%
奥麦罗制药盘中异动 早盘快速上涨5.30%报3.38美元
市场透视 · 06-18
奥麦罗制药盘中异动 早盘快速上涨5.30%报3.38美元
奥麦罗制药盘中异动 下午盘大幅下挫5.07%报3.37美元
市场透视 · 06-13
奥麦罗制药盘中异动 下午盘大幅下挫5.07%报3.37美元
奥麦罗制药盘中异动 快速跳水5.15%报3.68美元
市场透视 · 06-11
奥麦罗制药盘中异动 快速跳水5.15%报3.68美元
奥麦罗制药盘中异动 早盘急速下挫5.04%报3.58美元
市场透视 · 06-09
奥麦罗制药盘中异动 早盘急速下挫5.04%报3.58美元
奥麦罗制药盘中异动 早盘大幅拉升5.15%报3.47美元
市场透视 · 06-06
奥麦罗制药盘中异动 早盘大幅拉升5.15%报3.47美元
奥麦罗制药盘中异动 股价大涨5.10%
市场透视 · 06-04
奥麦罗制药盘中异动 股价大涨5.10%
奥麦罗制药盘中异动 早盘股价大涨5.10%
市场透视 · 05-29
奥麦罗制药盘中异动 早盘股价大涨5.10%
奥麦罗制药盘中异动 早盘股价大涨5.70%
市场透视 · 05-27
奥麦罗制药盘中异动 早盘股价大涨5.70%
加载更多
公司概况
公司名称:
奥麦罗制药
所属市场:
NASDAQ
上市日期:
--
主营业务:
Omeros Corporation在华盛顿成立。该公司正在推进多个开发项目,重点关注与补体系统相关的疾病和紊乱,补体系统是一组专门的蛋白质,可防止侵袭性病原体以及体内受损细胞,是人体免疫系统的重要组成部分。当触发时,补体的各种成分协同产生免疫反应,对抗感染并清除受损或死亡的细胞,维持身体系统的健康功能。然而,补体系统的失调(即过度激活或激活不足)可能是有害的,并且与感染和非感染性疾病的脆弱性增加有关,包括自身免疫性疾病、慢性炎症、血栓性微血管病和癌症。
发行价格:
--
{"stockData":{"symbol":"OMER","market":"US","secType":"STK","nameCN":"奥麦罗制药","latestPrice":3.61,"timestamp":1754078400000,"preClose":3.87,"halted":0,"volume":1863023,"hourTrading":{"tag":"盘后","latestPrice":3.56,"preClose":3.61,"latestTime":"16:53 EDT","volume":11086,"amount":39985.58,"timestamp":1754081623321},"delay":0,"floatShares":64550800,"shares":67126800,"eps":-2.64019,"marketStatus":"休市中","change":-0.26,"latestTime":"08-01 16:00:00 EDT","open":3.83,"high":3.83,"low":3.52,"amount":6771425.368812,"amplitude":0.080103,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.64019,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1254974400000,"exchange":"NASDAQ","adjPreClose":3.87,"preHourTrading":{"tag":"盘前","latestPrice":3.83,"preClose":3.87,"latestTime":"09:29 EDT","volume":930,"amount":3600.3958620000003,"timestamp":1754054999999},"postHourTrading":{"tag":"盘后","latestPrice":3.56,"preClose":3.61,"latestTime":"16:53 EDT","volume":11086,"amount":39985.58,"timestamp":1754081623321},"volumeRatio":0.6306315914616655,"impliedVol":1.4215,"impliedVolPercentile":0.976},"requestUrl":"/m/hq/s/OMER","defaultTab":"news","newsList":[{"id":"2556375958","title":"奥麦罗制药盘中异动 股价大涨5.06%报4.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556375958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556375958?lang=zh_cn&edition=full","pubTime":"2025-08-01 00:28","pubTimestamp":1753979336,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日00时28分,奥麦罗制药股票出现异动,股价大幅上涨5.06%。截至发稿,该股报4.05美元/股,成交量46.7757万股,换手率0.70%,振幅6.10%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为2.85%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080100285694c6b540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080100285694c6b540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2555068555","title":"奥麦罗制药盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555068555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555068555?lang=zh_cn&edition=full","pubTime":"2025-07-29 23:54","pubTimestamp":1753804484,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日23时54分,奥麦罗制药股票出现异动,股价快速跳水5.06%。截至发稿,该股报3.94美元/股,成交量78.8414万股,换手率1.35%,振幅6.99%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.36%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729235445a6c821d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729235445a6c821d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2554903772","title":"奥麦罗制药盘中异动 股价大涨7.96%报4.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554903772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554903772?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:35","pubTimestamp":1753709756,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时35分,奥麦罗制药股票出现异动,股价快速上涨7.96%。截至发稿,该股报4.14美元/股,成交量16.7217万股,换手率0.29%,振幅5.48%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.09%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213600a6c61749&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728213600a6c61749&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2551121349","title":"奥麦罗制药盘中异动 临近午盘股价大跌5.26%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551121349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551121349?lang=zh_cn&edition=full","pubTime":"2025-07-16 23:34","pubTimestamp":1752680098,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日23时34分,奥麦罗制药股票出现波动,股价急速下挫5.26%。截至发稿,该股报3.42美元/股,成交量31.1539万股,换手率0.53%,振幅7.06%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.96%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071623345997a89d8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071623345997a89d8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2551160876","title":"奥麦罗制药盘中异动 急速拉升5.07%报3.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551160876","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551160876?lang=zh_cn&edition=full","pubTime":"2025-07-15 01:47","pubTimestamp":1752515236,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日01时47分,奥麦罗制药股票出现波动,股价急速拉升5.07%。截至发稿,该股报3.84美元/股,成交量40.7562万股,换手率0.70%,振幅5.07%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.63%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715014716a44a730a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715014716a44a730a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2550695467","title":"奥麦罗制药盘中异动 大幅拉升5.06%报3.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550695467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550695467?lang=zh_cn&edition=full","pubTime":"2025-07-11 22:04","pubTimestamp":1752242649,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时04分,奥麦罗制药股票出现异动,股价大幅上涨5.06%。截至发稿,该股报3.64美元/股,成交量22.4609万股,换手率0.38%,振幅5.49%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体跌幅为0.67%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071122041097a266d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071122041097a266d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2550535916","title":"奥麦罗制药盘中异动 急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550535916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550535916?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:41","pubTimestamp":1752068469,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时41分,奥麦罗制药股票出现异动,股价急速拉升5.01%。截至发稿,该股报3.29美元/股,成交量5.6933万股,换手率0.10%,振幅3.83%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为1.08%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214110a69f901d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214110a69f901d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2549554764","title":"奥麦罗制药盘中异动 下午盘股价大跌5.00%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549554764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549554764?lang=zh_cn&edition=full","pubTime":"2025-07-08 02:15","pubTimestamp":1751912123,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日02时15分,奥麦罗制药股票出现波动,股价快速跳水5.00%。截至发稿,该股报3.04美元/股,成交量36.7718万股,换手率0.63%,振幅3.44%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体跌幅为1.00%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708021523a43c48e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708021523a43c48e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2548818925","title":"奥麦罗制药盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548818925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548818925?lang=zh_cn&edition=full","pubTime":"2025-07-02 22:00","pubTimestamp":1751464805,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日22时00分,奥麦罗制药股票出现异动,股价急速拉升5.05%。截至发稿,该股报3.12美元/股,成交量14.8169万股,换手率0.25%,振幅5.39%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.58%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222000595340490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070222000595340490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2548012133","title":"奥麦罗制药盘中异动 急速跳水5.00%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548012133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548012133?lang=zh_cn&edition=full","pubTime":"2025-07-01 02:54","pubTimestamp":1751309666,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日02时54分,奥麦罗制药股票出现异动,股价大幅下挫5.00%。截至发稿,该股报3.04美元/股,成交量69.1806万股,换手率1.18%,振幅4.84%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.07%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701025427a4c72d2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701025427a4c72d2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2546234737","title":"奥麦罗制药盘中异动 早盘快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546234737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546234737?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:12","pubTimestamp":1750950748,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日23时12分,奥麦罗制药股票出现异动,股价大幅下挫5.00%。截至发稿,该股报3.33美元/股,成交量22.648万股,换手率0.39%,振幅5.14%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.14%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626231228952cd294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626231228952cd294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2545313912","title":"奥麦罗制药盘中异动 快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545313912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545313912?lang=zh_cn&edition=full","pubTime":"2025-06-24 23:20","pubTimestamp":1750778459,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日23时20分,奥麦罗制药股票出现异动,股价快速上涨5.02%。截至发稿,该股报3.35美元/股,成交量22.6284万股,换手率0.39%,振幅5.02%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为1.72%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624232059a71b7a03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624232059a71b7a03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2544906719","title":"奥麦罗制药盘中异动 早盘快速上涨5.30%报3.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544906719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544906719?lang=zh_cn&edition=full","pubTime":"2025-06-18 23:09","pubTimestamp":1750259395,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日23时09分,奥麦罗制药股票出现异动,股价急速拉升5.30%。截至发稿,该股报3.38美元/股,成交量14.8534万股,换手率0.25%,振幅6.70%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.96%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061823095697853292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061823095697853292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2543349726","title":"奥麦罗制药盘中异动 下午盘大幅下挫5.07%报3.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543349726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543349726?lang=zh_cn&edition=full","pubTime":"2025-06-14 02:31","pubTimestamp":1749839467,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日02时31分,奥麦罗制药股票出现异动,股价急速下挫5.07%。截至发稿,该股报3.37美元/股,成交量34.692万股,换手率0.59%,振幅4.22%。机构评级方面,在所有5家参与评级的机构中,60%的券商给予买入建议,40%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体跌幅为0.78%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614023107a7080d10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614023107a7080d10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2542532801","title":"奥麦罗制药盘中异动 快速跳水5.15%报3.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542532801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542532801?lang=zh_cn&edition=full","pubTime":"2025-06-12 03:03","pubTimestamp":1749668603,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日03时03分,奥麦罗制药股票出现波动,股价急速跳水5.15%。截至发稿,该股报3.68美元/股,成交量57.2629万股,换手率0.98%,振幅8.25%。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.10%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612030323a704099d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612030323a704099d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2542335686","title":"奥麦罗制药盘中异动 早盘急速下挫5.04%报3.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542335686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542335686?lang=zh_cn&edition=full","pubTime":"2025-06-09 23:05","pubTimestamp":1749481547,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日23时05分,奥麦罗制药股票出现波动,股价快速跳水5.04%。截至发稿,该股报3.58美元/股,成交量23.7363万股,换手率0.41%,振幅7.43%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.66%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092305479514ece7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092305479514ece7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2541636898","title":"奥麦罗制药盘中异动 早盘大幅拉升5.15%报3.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541636898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541636898?lang=zh_cn&edition=full","pubTime":"2025-06-06 21:30","pubTimestamp":1749216657,"startTime":"0","endTime":"0","summary":"北京时间2025年06月06日21时30分,奥麦罗制药股票出现异动,股价大幅上涨5.15%。截至发稿,该股报3.47美元/股,成交量4655股,换手率0.01%,振幅1.82%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.00%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213058977470b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606213058977470b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2541403095","title":"奥麦罗制药盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541403095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541403095?lang=zh_cn&edition=full","pubTime":"2025-06-05 03:02","pubTimestamp":1749063778,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日03时02分,奥麦罗制药股票出现异动,股价快速拉升5.10%。截至发稿,该股报3.30美元/股,成交量50.2059万股,换手率0.86%,振幅6.05%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.09%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605030258950ee0d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605030258950ee0d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2539134266","title":"奥麦罗制药盘中异动 早盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539134266","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539134266?lang=zh_cn&edition=full","pubTime":"2025-05-29 21:57","pubTimestamp":1748527046,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日21时57分,奥麦罗制药股票出现异动,股价急速上涨5.10%。截至发稿,该股报3.30美元/股,成交量9.8723万股,换手率0.17%,振幅6.69%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.55%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529215726a6f1f6aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529215726a6f1f6aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2538467630","title":"奥麦罗制药盘中异动 早盘股价大涨5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538467630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538467630?lang=zh_cn&edition=full","pubTime":"2025-05-27 21:31","pubTimestamp":1748352705,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日21时31分,奥麦罗制药股票出现波动,股价快速上涨5.70%。截至发稿,该股报3.34美元/股,成交量2.1195万股,换手率0.04%,振幅3.80%。机构评级方面,在所有4家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。奥麦罗制药股票所在的生物技术行业中,整体涨幅为0.65%。narsoplimab 的临床开发目前集中在造血干细胞移植相关的血栓性微血管病和免疫球蛋白肾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052721314597673e7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052721314597673e7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMER","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.omeros.com","stockEarnings":[{"period":"1week","weight":-0.0574},{"period":"1month","weight":0.1683},{"period":"3month","weight":-0.4965},{"period":"6month","weight":-0.5812},{"period":"1year","weight":-0.2809},{"period":"ytd","weight":-0.6346}],"compareEarnings":[{"period":"1week","weight":-0.0241},{"period":"1month","weight":0.002},{"period":"3month","weight":0.097},{"period":"6month","weight":0.0331},{"period":"1year","weight":0.145},{"period":"ytd","weight":0.0608}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Omeros Corporation在华盛顿成立。该公司正在推进多个开发项目,重点关注与补体系统相关的疾病和紊乱,补体系统是一组专门的蛋白质,可防止侵袭性病原体以及体内受损细胞,是人体免疫系统的重要组成部分。当触发时,补体的各种成分协同产生免疫反应,对抗感染并清除受损或死亡的细胞,维持身体系统的健康功能。然而,补体系统的失调(即过度激活或激活不足)可能是有害的,并且与感染和非感染性疾病的脆弱性增加有关,包括自身免疫性疾病、慢性炎症、血栓性微血管病和癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.006425},{"month":2,"riseRate":0.5625,"avgChangeRate":0.058594},{"month":3,"riseRate":0.625,"avgChangeRate":0.097428},{"month":4,"riseRate":0.375,"avgChangeRate":-0.031657},{"month":5,"riseRate":0.375,"avgChangeRate":-0.032445},{"month":6,"riseRate":0.3125,"avgChangeRate":0.036171},{"month":7,"riseRate":0.4375,"avgChangeRate":0.065457},{"month":8,"riseRate":0.25,"avgChangeRate":-0.038179},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.000881},{"month":10,"riseRate":0.466667,"avgChangeRate":-0.097378},{"month":11,"riseRate":0.625,"avgChangeRate":0.230689},{"month":12,"riseRate":0.5,"avgChangeRate":0.021535}],"exchange":"NASDAQ","name":"奥麦罗制药","nameEN":"Omeros"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥麦罗制药(OMER)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥麦罗制药(OMER)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥麦罗制药,OMER,奥麦罗制药股票,奥麦罗制药股票老虎,奥麦罗制药股票老虎国际,奥麦罗制药行情,奥麦罗制药股票行情,奥麦罗制药股价,奥麦罗制药股市,奥麦罗制药股票价格,奥麦罗制药股票交易,奥麦罗制药股票购买,奥麦罗制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥麦罗制药(OMER)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥麦罗制药(OMER)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}